Clinical Trial Update: Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemoradiotherapy with targeted immunotherapy for pediatric lymphomas. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: New York Medical College | Conditions: Non-hodgkin Lymphoma, Hodgkin Lymphoma | Phase 2 | Status: RECRUITING